Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Zhi-g Yan is active.

Publication


Featured researches published by Zhi-g Yan.


Bioorganic & Medicinal Chemistry Letters | 2017

Flavonoids and their derivatives with β-amyloid aggregation inhibitory activity from the leaves and twigs of Pithecellobium clypearia Benth

Yu-Xi Wang; Qiang Ren; Zhi-Yang Yan; Wei Wang; Lu Zhao; Ming Bai; Xiao-Bo Wang; Xiao-Xiao Huang; Shao-Jiang Song

To explore potential compounds with marked effect on Alzheimers disease (AD) in Pithecellobium clypearia Benth., nineteen compounds (1-19) were obtained, including two new flavonoid derivatives, named pithecellobiumol A (1) and pithecellobiumol B (2) and 17 flavonoids (3-19). Their structures were elucidated based on 1D and 2D-NMR spectra as well as HR-ESI-MS data. The absolute configurations of new compounds were assigned by comparing their experimental specific rotation or ECD curves with the calculated data. The inhibitory activity on Aβ aggregation was screened by ThT assay, and compounds 7 (70.7%), 9 (86.5%), 10 (88.4%), 15 (86.1%) and 16 (87.7%) showed outstanding inhibition rate at 20μM compared to the positive control, curcumin (65.64%). In addition, docking study was performed to initially examine possible molecular mechanisms. Considering the important role of oxidative stress in AD, all the isolated compounds were tested for their H2O2-induced damage in human neuronblastoma SH-SY5Y cells. Among them, compound 16 (91.0%) was the most potent candidate in the treatment of AD.


Natural Product Research | 2018

Network pharmacology-based screening of the active ingredients and potential targets of the genus of Pithecellobium marthae (Britton & Killip) Niezgoda & Nevl for application to Alzheimer’s disease

Han Zhang; Zhi-Yang Yan; Yu-Xi Wang; Ming Bai; Xiao-Bo Wang; Xiao-Xiao Huang; Shao-Jiang Song

Abstract Alzheimer’s disease (AD) is a progressive neurodegenerative disorder associated with synaptic dysfunction, pathological accumulation of β-amyloid (Aβ), and neuronal loss. Given the prevalence of AD and the lack of effective long-term therapies, there is a pressing need to discover viable leads that can be developed into clinically approved drugs with disease-modifying effects. The analysis of current reported literatures confirms the importance of the plants of Pithecellobium genus as candidate against AD. Hence, it is necessary to identify selective anti-dementia agents from this genus. To explore potential compounds with marked effect on AD in Pithecellobium genus, a compound database based on the methods of network pharmacology prediction was established in this paper by constructing the compound-disease target network. The result showed that the most effective compound in the plants of this genus might be (7′R,8′R)-7′-methoxyl strebluslignanol, and the most potential target might be Macrophage colony-stimulating factor 1 receptor.


Journal of Asian Natural Products Research | 2018

Investigation of chemical constituents of safflower and their tyrosinase inhibitory activity

Xiao-Xiao Huang; Zhi-Yang Yan; Sen Liu; Xiao-Bo Wang; Shao-Jiang Song

Abstract Investigation on bioactive chemical constituents of safflower led to the isolation of 10 compounds from the aqueous extract, including a new alkaloid (1), a new glucopyranoside (2), and 8 known compounds (3–10). The structures of two new compounds were elucidated on the basis of extensive spectral analyses, including 1D, 2D-NMR and HRESIMS. Biological research on the isolates indicated that compounds 3, 4 and 9 remarkably inhibited tyrosinase with IC50 at 0.11, 0.20 and 0.11 mM, respectively, compared with the positive control arbutin (0.26 mM). To investigate the interaction between enzyme and isolated compounds, an in silico docking study was carried out. The research provided valuable experience for phytochemistry and biological investigation on safflower.


Fitoterapia | 2018

Racemic phenylpropanoids from the root barks of Ailanthus altissima (Mill.) Swingle with cytotoxicity against hepatoma cells

Zhi-Yang Yan; Jing-Jie Chen; Zhi-Kang Duan; Guo-Dong Yao; Bin Lin; Xiao-Bo Wang; Xiao-Xiao Huang; Shao-Jiang Song

Four pairs of racemic phenylpropanoids (1a/1b-4a/4b), including five new compounds (1a/1b, 2a, 3a, and 4a) were obtained from the root barks of Ailanthus altissima (Mill.) Swingle. Their structures were determined by comprehensive spectroscopic analyses. The absolute configurations of the enantiomers were determined by comparison of the experimental ECD and OR with the calculated data. The antitumor activity of all isolates was evaluated against two human hepatoma carcinoma cells (HepG2 and Hep3B) in vitro. It was demonstrated that 1a/1b showed potent selective cytotoxicity against HepG2 cells. Additionally, 1a/1b could also induce apoptosis enantioselectively as demonstrated by Hoechst staining experiment.


亚洲传统医药 | 2018

Main chemical constituents and pharmacologicalproperties of Harrisonia perforata (Blanco) Merr.

Shifang Li; Zhi-Yang Yan; Xiao-Xiao Huang; Shao-Jiang Song


亚洲传统医药 | 2018

Chemical constituents of the genus Pithecellobium:a systematic review

Han Zhang; Zhi-Yang Yan; Xiao-Xiao Huang


亚洲传统医药 | 2018

Screening of potential active compounds in Eurycoma longifoliaagainst hepatic carcinoma by Network pharmacology

Chunxin Zou; Wen-Yu Zhao; Zhi-Yang Yan; Xiao-Xiao Huang; Shao-Jiang Song; Xiaobo Wan


Industrial Crops and Products | 2018

Prunus tomentosa seed waste as a source of aromatic glycosides: Valuable phytochemicals with α-glucosidase inhibitory and hepatoprotective properties

Qing-Bo Liu; Zhuo-Yang Cheng; Zhi-Yang Yan; Di Wang; Ming Bai; Xiao-Xiao Huang; Shao-Jiang Song


亚洲传统医药 | 2017

Phenolic compounds from Pithecellobiumclypearia with tyrosinase inhibitory activity

Han Zhang; Zhi-Yang Yan; Yu-Xi Wang; Xiao-Xiao Huang


亚洲传统医药 | 2017

Eurycoma longifolia (Simarubaceae); Review onits Chemical Constituents

Chunxin Zou; Zhi-Yang Yan; Wen-Yu Zhao; Xiao-Xiao Huang; Shao-Jiang Song; Xiaobo Wa

Collaboration


Dive into the Zhi-g Yan's collaboration.

Top Co-Authors

Avatar

Xiao-Xiao Huang

Shenyang Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar

Shao-Jiang Song

Shenyang Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar

Xiao-Bo Wang

Shenyang Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar

Han Zhang

Shenyang Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar

Ming Bai

Shenyang Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar

Yu-Xi Wang

Shenyang Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar

Bin Lin

Shenyang Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar

Sen Liu

Shenyang Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar

Wen-Yu Zhao

Shenyang Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar

Di Wang

Shenyang Pharmaceutical University

View shared research outputs
Researchain Logo
Decentralizing Knowledge